Adagio Medical Holdings Inc (ADGM) Stock Price, Quote & News

Company Profile

Adagio Medical Holdings, Inc., a medical technology company, focuses on the development and commercialization of ablation technologies for the treatment of cardiac arrhythmias. It offers treatment for cardiac arrhythmias, including atrial fibrillation, and ventricular tachycardia. The company's product portfolio includes iCLAS atrial ultra-low temperature ablation (ULTA) catheter and system; vCLAS ventricular ULTC catheter; and Cryopulse pulsed field cryoablation catheters. Adagio Medical Holdin...

Industry: Medical Devices

Sector: Healthcare

Phone: 949 348 1188

Website: adagiomedical.com

Address:

26051 Merit Circle, Suite 102, Laguna Hills, United States

87trades Jul. 2 at 1:52 PM

$ADGM still allergic to .70s However, it did have 50x the volume PM that it had all day yesterday 😂

0 · Reply

SearchFor911 Jul. 2 at 8:48 AM

$ADGM strange behaviour this morning 🎁🎁🎁

0 · Reply

Doxtator Jul. 1 at 9:41 PM

$ADGM We find out if the FDA accepts the PMA for review very soon…

0 · Reply

Rafa007 Jul. 1 at 2:23 PM

$ADGM ???????????....bha

1 · Reply

87trades Jun. 30 at 3:14 PM

$ADGM allergic to the .70s

1 · Reply

87trades Jun. 26 at 11:55 AM

$ADGM today we touch the .50s and the long path to r/s

1 · Reply

Rafa007 Jun. 26 at 10:28 AM

$ADGM only garbage .....teed......tnks

0 · Reply

Maej20 Jun. 26 at 1:36 AM

$ADGM One of my biggest mistakes in stock trading is marrying a stock based on a hopeful future narrative, a pattern I've repeated with more than one stock, resulting in significant losses. I don't know if this stock will be an exception; the losses are still substantial.

0 · Reply

87trades Jun. 25 at 11:07 PM

$ADGM

0 · Reply

MrDaniels Jun. 25 at 7:51 PM

$ADGM the new ILLR?

0 · Reply

Adagio Medical Holdings Transcript: AGM 2026

2026-06-03T11:16:54.000Z - 4 weeks ago

Adagio Medical initiated with a Buy at Lucid Capital

2026-05-21T12:12:18.000Z - 6 weeks ago

Adagio Medical submits PMA application to FDA for vCLAS Ventricular Ablation

May 21, 2026, 8:00 AM EDT - 6 weeks ago

Adagio Medical Submits Premarket Approval Application to FDA for vCLAS® Ventricular Ablation System for the Treatment of Ventricular Tachycardia

May 13, 2026, 7:00 AM EDT - 7 weeks ago

Adagio Medical Holdings Transcript: BofA Securities 2026 Health Care Conference

May 13, 2026, 7:00 AM EDT - 7 weeks ago

Adagio Medical Holdings Slides: FY 2026

May 12, 2026, 8:05 AM EDT - 7 weeks ago

Adagio Medical Reports First Quarter 2026 Results and Meaningful Clinical Progress

May 12, 2026, 8:00 AM EDT - 7 weeks ago

Adagio Medical Holdings Quarterly report: Q1 2026

May 12, 2026, 8:00 AM EDT - 7 weeks ago

Adagio Medical Holdings Earnings release: Q1 2026

Apr 30, 2026, 8:00 AM EDT - 2 months ago

Adagio Medical Holdings Proxy statement: Proxy filing

Apr 29, 2026, 8:00 AM EDT - 2 months ago

Adagio Medical to Participate in the BofA Securities 2026 Health Care Conference

Apr 27, 2026, 7:00 AM EDT - 2 months ago

Adagio Medical Holdings Transcript: KOL event

Apr 27, 2026, 7:00 AM EDT - 2 months ago

Adagio Medical Holdings Slides: KOL event

2026-04-26T17:30:32.000Z - 2 months ago

Adagio Medical reports six-month results from Fulcrum-VT IDE trial

Apr 26, 2026, 9:32 AM EDT - 2 months ago

Adagio Medical Announces Positive Pivotal Results for vCLAS® Ventricular Ablation System

Apr 16, 2026, 8:00 AM EDT - 2 months ago

Adagio Medical's ULTA Technology to Be Featured at the Heart Rhythm 2026 Conference

Apr 14, 2026, 7:00 AM EDT - 2 months ago

Adagio Medical Holdings Transcript: 25th Annual Needham Virtual Healthcare Conference

Apr 14, 2026, 7:00 AM EDT - 2 months ago

Adagio Medical Holdings Slides: 25th Annual Needham Virtual Healthcare Conference

2026-04-14T09:20:20.000Z - 2 months ago

Adagio Medical initiated with an Overweight at Piper Sandler

2026-04-08T12:16:25.000Z - 3 months ago

Adagio Medical announces FDA granted IDE approval for FULCRUM-VT trial

Apr 8, 2026, 8:00 AM EDT - 3 months ago

Adagio Medical Receives IDE Approval from the FDA to Investigate Next-Generation vCLAS® Ventricular Ablation System

Apr 6, 2026, 8:00 AM EDT - 3 months ago

Adagio Medical to Participate in the 25th Annual Needham Virtual Conference

Apr 1, 2026, 8:00 AM EDT - 3 months ago

Adagio Medical Ultralow Temperature Ablation U.S. Pivotal Study Results to be Presented in Late-Breaking Session at Heart Rhythm Society 2026

Mar 27, 2026, 8:00 AM EDT - 3 months ago

Adagio Medical Reports Fourth Quarter and Full Year 2025 Results

Mar 27, 2026, 8:00 AM EDT - 3 months ago

Adagio Medical Holdings Annual report: Q4 2025

Mar 27, 2026, 8:00 AM EDT - 3 months ago

Adagio Medical Holdings Earnings release: Q4 2025

2026-03-24T12:21:22.000Z - 3 months ago

Adagio announces preclinical results for ventricular ablation catheter

Mar 24, 2026, 8:00 AM EDT - 3 months ago

Adagio Medical Announces Publication of Pre-Clinical Results for Next Generation Ventricular Ablation Catheter

Mar 19, 2026, 8:00 AM EDT - 3 months ago

Adagio Medical Highlights Recent Successful Expanded Access Cases with vCLAS™ System, Including Patients with Premature Ventricular Contractions (PVC)

Mar 11, 2026, 8:00 AM EDT - 4 months ago

Adagio Medical to Participate in the 38th Annual Roth Conference

Feb 20, 2026, 8:00 AM EST - 4 months ago

Adagio Medical to Participate in the TD Cowen 46th Annual Healthcare Conference

Feb 5, 2026, 7:00 AM EST - 5 months ago

Adagio Medical Holdings Transcript: Small Cap Growth Virtual Investor Conference

2026-02-04T14:20:26.000Z - 5 months ago

Adagio Medical highlights favorable safety profile in cardiac ablation study

Feb 4, 2026, 8:00 AM EST - 5 months ago

New Adagio Medical Publication Highlights Consistent Safety and Effectiveness with Ultralow Temperature Ablation in Broad Range of Patients with Ventricular Tachycardia

Feb 2, 2026, 8:05 AM EST - 5 months ago

Adagio Medical to Participate at the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference

Jan 30, 2026, 8:35 AM EST - 5 months ago

Adagio Medical to Present at the Small Cap Growth Virtual Investor Conference February 5th

Dec 22, 2025, 8:00 AM EST - 6 months ago

Adagio Medical Appoints Two Seasoned Senior Executives to Accelerate Commercial Readiness

Dec 11, 2025, 8:00 AM EST - 7 months ago

Adagio Medical Appoints Industry Veteran Sean Salmon to Board of Directors

Dec 11, 2025, 7:00 AM EST - 7 months ago

Adagio Medical Holdings Proxy statement: Proxy filing

2025-12-02T13:27:19.000Z - 7 months ago

Adagio Medical initiated with a Buy at Lake Street

Nov 24, 2025, 7:00 AM EST - 7 months ago

Adagio Medical Holdings Registration statement: Registration filing

Nov 12, 2025, 4:05 PM EST - 8 months ago

Adagio Medical Reports Third Quarter 2025 Results

Nov 12, 2025, 7:00 AM EST - 8 months ago

Adagio Medical Holdings Quarterly report: Q3 2025

Nov 12, 2025, 7:00 AM EST - 8 months ago

Adagio Medical Holdings Earnings release: Q3 2025

Nov 5, 2025, 8:00 AM EST - 8 months ago

Adagio Medical to Present at the Piper Sandler 37th Annual Healthcare Conference

Nov 4, 2025, 7:00 AM EST - 8 months ago

Adagio Medical Holdings Proxy statement: Proxy filing

Oct 20, 2025, 8:00 AM EDT - 9 months ago

Adagio Medical Closes Financing of $19 Million Upfront; Positions Company to Advance Purpose-Built Technology for Treatment of Ventricular Tachycardia

Oct 15, 2025, 8:00 AM EDT - 9 months ago

Adagio Medical Announces Pricing of up to $50 Million Private Placement of Securities

2025-10-10T19:45:16.000Z - 9 months ago

Adagio Medical announces preliminary acute results from FULCRUM-VT study

Oct 10, 2025, 3:40 PM EDT - 9 months ago

Adagio Medical Unveils Preliminary Acute Results from FULCRUM-VT U.S. Pivotal Study in Late Breaking Session at VT Symposium

2025-10-01T12:15:11.000Z - 9 months ago

Adagio Medical completes enrollment in FULCRUM-VT trial

Oct 1, 2025, 8:00 AM EDT - 9 months ago

Adagio Medical, Inc. Announces Completion of Enrollment for FULCRUM-VT Pivotal Clinical Trial Evaluating Ultra-Low Temperature Cryoablation for Ventricular Tachycardia

Sep 18, 2025, 8:00 AM EDT - 10 months ago

Adagio Medical FULCRUM-VT U.S. Pivotal Study Acute Results to be Presented in Late-Breaking Session at VT Symposium

Sep 8, 2025, 8:00 AM EDT - 10 months ago

Adagio Medical Expands Chief Business Officer Deborah Kaster's Role to Include Chief Financial Officer Responsibilities

Aug 14, 2025, 8:00 AM EDT - 11 months ago

Adagio Medical Holdings Quarterly report: Q2 2025

Aug 14, 2025, 8:00 AM EDT - 11 months ago

Adagio Medical Holdings Earnings release: Q2 2025

Aug 13, 2025, 4:30 PM EDT - 11 months ago

Adagio Medical Reports Second Quarter 2025 Results

May 15, 2025, 4:05 PM EDT - 1 year ago

Adagio Medical Reports First Quarter 2025 Results

May 15, 2025, 8:00 AM EDT - 1 year ago

Adagio Medical Holdings Quarterly report: Q1 2025

May 15, 2025, 8:00 AM EDT - 1 year ago

Adagio Medical Holdings Earnings release: Q1 2025

May 7, 2025, 8:30 AM EDT - 1 year ago

Adagio Medical to Present at the BofA Securities 2025 Health Care Conference

2025-04-17T13:10:54.000Z - 1 year ago

Adagio Medical receives FDA Breakthrough Device designation for vCLAS system

Apr 17, 2025, 8:30 AM EDT - 1 year ago

Adagio Medical Holdings, Inc. Receives FDA Breakthrough Device Designation for the vCLASTM Cryoablation System

2025-03-31T20:05:42.000Z - 1 year ago

Adagio Medical names Deborah Kaster CBO

Mar 31, 2025, 4:01 PM EDT - 1 year ago

Adagio Medical Appoints Deborah Kaster as Chief Business Officer

Mar 31, 2025, 8:30 AM EDT - 1 year ago

Adagio Medical Reports Fourth Quarter and Full Year 2024 Results

Mar 27, 2025, 8:00 AM EDT - 1 year ago

Adagio Medical Holdings Annual report: Q4 2024

Mar 27, 2025, 8:00 AM EDT - 1 year ago

Adagio Medical Holdings Earnings release: Q4 2024

Mar 17, 2025, 4:01 PM EDT - 1 year ago

Adagio Medical Provides Clinical and Business Updates

2025-02-28T13:36:12.000Z - 1 year ago

Adagio Medical to reduce workforce in strategic restructuring

Feb 28, 2025, 8:30 AM EST - 1 year ago

Adagio Medical Announces Strategic Restructuring to Accelerate US Pivotal IDE Trial and Product Innovation

Feb 18, 2025, 4:01 PM EST - 1 year ago

Adagio Medical to Participate at the TD Cowen's 45th Annual Health Care Conference

Feb 4, 2025, 7:00 AM EST - 1 year ago

Adagio Medical Holdings Registration statement: Registration filing

Feb 4, 2025, 7:00 AM EST - 1 year ago

Adagio Medical Holdings Registration statement: Registration filing

Jan 14, 2025, 7:00 AM EST - 1 year ago

Adagio Medical Holdings Registration statement: Registration filing

Jan 14, 2025, 7:00 AM EST - 1 year ago

Adagio Medical Holdings Registration statement: Registration filing

Dec 16, 2024, 8:00 AM EST - 1 year ago

Adagio Medical Announces Appointment of Accomplished Medical Device Leader Todd Usen as Chief Executive Officer and Director

Nov 14, 2024, 4:01 PM EST - 1 year ago

Adagio Medical Reports Third Quarter 2024 Results

Nov 14, 2024, 7:00 AM EST - 1 year ago

Adagio Medical Holdings Quarterly report: Q3 2024

Nov 14, 2024, 7:00 AM EST - 1 year ago

Adagio Medical Holdings Earnings release: Q3 2024

Nov 4, 2024, 4:01 PM EST - 1 year ago

Adagio Medical to Present at the Stifel 2024 Healthcare Conference

Oct 24, 2024, 8:30 AM EDT - 1 year ago

Adagio Medical Announces Completion of First Procedures in FULCRUM-VT U.S. FDA Pivotal IDE of Ventricular Tachycardia Cryoablation System

Oct 7, 2024, 4:01 PM EDT - 1 year ago

Adagio Medical Announces Participation in the 19th Annual International Symposium on Ventricular Arrhythmias

Sep 13, 2024, 8:00 AM EDT - 1 year ago

Adagio Medical Holdings Registration statement: Registration filing

Sep 13, 2024, 8:00 AM EDT - 1 year ago

Adagio Medical Holdings Registration statement: Registration filing

Aug 26, 2024, 8:00 AM EDT - 2 years ago

Adagio Medical Holdings Quarterly report: Q2 2024

Aug 19, 2024, 4:01 PM EDT - 2 years ago

Adagio Medical Provides Business Updates

87trades Jul. 2 at 1:52 PM

$ADGM still allergic to .70s However, it did have 50x the volume PM that it had all day yesterday 😂

0 · Reply

SearchFor911 Jul. 2 at 8:48 AM

$ADGM strange behaviour this morning 🎁🎁🎁

0 · Reply

Doxtator Jul. 1 at 9:41 PM

$ADGM We find out if the FDA accepts the PMA for review very soon…

0 · Reply

Rafa007 Jul. 1 at 2:23 PM

$ADGM ???????????....bha

1 · Reply

87trades Jun. 30 at 3:14 PM

$ADGM allergic to the .70s

1 · Reply

87trades Jun. 26 at 11:55 AM

$ADGM today we touch the .50s and the long path to r/s

1 · Reply

Rafa007 Jun. 26 at 10:28 AM

$ADGM only garbage .....teed......tnks

0 · Reply

Maej20 Jun. 26 at 1:36 AM

0 · Reply

87trades Jun. 25 at 11:07 PM

$ADGM

0 · Reply

MrDaniels Jun. 25 at 7:51 PM

$ADGM the new ILLR?

0 · Reply

SearchFor911 Jun. 25 at 6:29 PM

$ADGM could someone buy this please.

1 · Reply

23Benny Jun. 24 at 9:17 PM

$CSAI This is back to back post lmao !!!! Likely to break a dollar soon 😂🤣😂🤣….checkout his other prediction…do i need to tell what $ADGM is at right now. 🤣😂🤣😂🤣 BUYERS BEWARE YOU HAVE AN IDIOT PUMPER IN THE CHAT !!!!!

1 · Reply

87trades Jun. 24 at 6:14 PM

$ADGM radiosilence from ceo and Lake St/Piper not updating after data all suggest financing/offering is in the works. Insane that they had company value at $100 mil in Oct with pipe. Offering may be the same size as float. 🤯

2 · Reply

SearchFor911 Jun. 24 at 4:46 PM

$ADGM stock will be dead soon. chapter 11

2 · Reply

Rafa007 Jun. 24 at 8:11 AM

$ADGM garbage

0 · Reply

MrDaniels Jun. 23 at 2:44 PM

$ADGM jumping in.

1 · Reply

PLX_BULLS Jun. 23 at 2:00 PM

$ADGM another 52 week low!

0 · Reply

SearchFor911 Jun. 22 at 3:01 PM

$ADGM destroying this to all time low...

1 · Reply

PLX_BULLS Jun. 17 at 8:25 PM

$ADGM close with a 52 week ain’t good!

1 · Reply

Sisms Jun. 17 at 3:03 PM

$ADGM Expected to rise 500% soon.

0 · Reply

focafoca99 Jun. 17 at 4:13 AM

$ADGM recorded its 2026 annual meeting, electing two directors and ratifying its auditor.

0 · Reply

SearchFor911 Jun. 15 at 7:33 PM

$ADGM come on, FDA. Let's do it

1 · Reply

Market Cap	14.15M
Revenue (ttm)	0.00
Net Income (ttm)	-25.08M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	3.99

Volume	148,800
Avg Vol	112,090
Day's Range	N/A - N/A
Shares Out	22.21M
Stochastic %K	17%
Beta	-0.19
Analysts	Strong Sell
Price Target	$3.50